Insulin-like growth factor-I improves chondrogenesis of predifferentiated human umbilical cord mesenchymal stromal cells

Journal of Orthopaedic Research

Volumn 27, Issue 8, 2009, Pages 1109-1115

  Wang, Limin ^a   Detamore, Michael S ^a  

^a University of Kansas   (United States)

Author keywords

Chondrogenic differentiation; IGF I; Stem cells; TGF beta3; Umbilical cord

Indexed keywords

AGGRECAN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; DNA; GLYCOSAMINOGLYCAN; HYDROXYPROLINE; POLYGLYCOLIC ACID; RNA; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA3;

ADULT STEM CELL; ARTICLE; BIOSYNTHESIS; CARTILAGE MATRIX; CELL CULTURE; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; DNA CONTENT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; PREDIFFERENTIATED CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION; STROMA CELL; TISSUE ENGINEERING; TISSUE EXPANSION; UMBILICAL CORD;

CELLS, CULTURED; CHONDROGENESIS; COLLAGEN TYPE I; COLLAGEN TYPE II; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA3; UMBILICAL CORD;

EID: 67749135391     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20848     Document Type: Article

References (26)

1. Can A, Karahuseyinoglu S. 2007. Concise review: human umbilical cord stroma with regard to the source of fetusderived stem cells. Stem Cells 25:2886-2895.
2. Troyer DL, Weiss ML. 2008. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591-599.
3. Dominici M, Le Blanc K, Mueller I, et al. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
4. Wang HS, Hung SC, Peng ST, et al. 2004. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22:1330-1337.
5. Karahuseyinoglu S, Cinar O, Kilic E, et al. 2007. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 25:319-331.
6. Baksh D, Yao R, Tuan RS. 2007. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384-1392.
7. Lu LL, Liu YJ, Yang SG, et al. 2006. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026.
8. Fu YS, Cheng YC, Lin MY, et al. 2006. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24:115-124.
9. Eblenkamp M, Aigner J, Hintermair J, et al. 2004. Umbilical cord stromal cells (UCSC). Cells featuring osteogenic differentiation potential. Orthopade 33:1338-1345.
10. Sarugaser R, Lickorish D, Baksh D, et al. 2005. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23:220-229.
11. Barry F, Boynton RE, Liu B, et al. 2001. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 268:189-200.
12. Bailey MM, Wang L, Bode CJ, et al. 2007. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 13:2003-2010.
13. Wang L, Seshareddy K, Weiss ML, et al. 2008. Effect of initial seeding density on human umbilical cord mesenchymal stromal cells for fibrocartilage tissue engineering. Tissue Eng (Part A), Epub ahead of print:1-9.
14. Ross RJ, Rodriguez-Arnao J, Bentham J, et al. 1993. The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill. Intensive Care Med 19(Suppl 2):S54-S57.
15. Kasukawa Y, Miyakoshi N, Mohan S. 2004. The anabolic effects of GH/IGF system on bone. Curr Pharm Des 10:2577-2592.
16. Schulze PC, Spate U. 2005. Insulin-like growth factor-1 and muscle wasting in chronic heart failure. Int J Biochem Cell Biol 37:2023-2035.
17. Im GI, Jung NH, Tae SK. 2006. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng 12:527-536.
18. Longobardi L, O'Rear L, Aakula S, et al. 2006. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21:626-636.
19. Wang L, Lazebnik M, Detamore MS. 2008. Hyaline cartilage cells outperform mandibular condylar cartilage cells in a TMJ fibrocartilage tissue engineering application. Osteoarthritis Cartilage, Epub ahead of print:1-8.
20. Wang L, Detamore MS. 2009. Effects of growth factors and glucosamine on porcine mandibular condylar cartilage cells and hyaline cartilage cells for tissue engineering applications. Arch Oral Biol 54:1-5.
21. Indrawattana N, Chen G, Tadokoro M, et al. 2004. Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun 320:914-919.
22. Worster AA, Brower-Toland BD, Fortier LA, et al. 2001. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 19:738-749.
23. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
24. Detamore MS, Athanasiou KA. 2005. Evaluation of three growth factors for TMJ disc tissue engineering. Ann Biomed Eng 33:383-390.
25. Makower AM, Wroblewski J, Pawlowski A. 1989. Effects of IGF-I, rGH, FGF, EGF and NCS on DNA-synthesis, cell proliferation and morphology of chondrocytes isolated from rat rib growth cartilage. Cell Biol Int Rep 13:259-270.
26. Jaklenec A, Hinckfuss A, Bilgen B, et al. 2008. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials 29:1518-1525.